All Type of News
Multinational firms urged to abide by fair trade code
The Korea Pharmaceutical Manufacturers Association said that multinational drug manufactures to observe its revised guideline aiming at making the local marketing activities transparent, under the consent of the Fair ...
US FDA approves phase 3 trial for new biological drug
Apimeds Inc., a local biopharmaceutical company, said it has received approval from the U.S. Food and Drug Administration to conduct Phase III clinical trial of a drug for the treatment of autoimmune disease and pain ...
133 Korean generics deemed expensive
A survey of 133 medicinal products showed that Korean medicines are more expensive than branded products.
The Health Insurance Review and Assessment Service reported recently that a total of 133 generics belonging ...
Kyungdong Pharm takes over Shinil Pharm
Insolvent Shinil Pharm said on June 4 that Kyungdong Pharm has signed a deal to take a controlling stake in the local wholesaling firm.
The deal will provide a big boost for the sales of Kyungdong in Chungju, accor...
Ahngook teams up with Biocopea over theobromine
Ahngook Pharma concluded a licensing-out agreement with U.K. based Biocopea Corporation on April 13, 2009, granting Biocopea exclusive patents rights in the U.S. and Europe for the sale of theobromine, a nonnarcotic e...
KPTA to appoint top executives
The Korea Pharmaceutical Manufacturers Association will select the next executives on June 9 after Auh June-sun, the former president, resigned last February in protest against the cash reward plan for doctors and pha...
Government urged to promote pharmaceutical industry
There are mounting concerns over the government’s one-side policy to lower drug prices by eliminating kickbacks from the pharmaceutical industry
These days, pharmaceutical companies face the government’s intensive...
Pharmacists defies DUR questionnaire list for OTCs
Despite the government’s plan to distribute the list of Drug Utilization Review (DUR) system related questionnnaire for efficient management of over-the-counter drugs but pharmacists are unwilling to utilize the list....
Oriental medicines' price hike upsets consumers
Starting June 1, leading drug makers raised the prices of the most popular oriental medicines such as “Chungshimwon” in the range of 20 to 25 percent.
It was the company's first price increase in a couple of years...
Hanall acquires local patent for combination bill
Hanall Biopharma said on June 4 that it won a Korean patent for a combination product containing thiazide and angiotensin receptor block for treatment of hypertension.
Hanall said its studies have shown that patien...
